Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

Conference Reports for NATAP

HIV Drug Therapy Glasgow 2024
10-13 November


Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

	Glasgow 2024 Nov 10-13